Keryx Biopharma (KERX) Files $100M Mixed Securities Shelf
Keryx Biopharma (Nasdaq: KERX) filed for a $100 million mixed securities shelf.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AcelRx Pharma (ACRX) Files to Sell up to $40M of Common Stock
- Golden Entertainment, Inc. (GDEN) Files $150M Mixed Shelf
- Izea Inc. Common (IZEA) Files $75M Common Stock Shelf
Create E-mail Alert Related CategoriesEquity Offerings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!